In April 2024, a research team at Mayo Clinic published a small clinical trial. Ten people with traumatic spinal cord injury received an infusion of stem cells grown from their own fat tissue. ChiroMed does not provide this treatment. Neither Florida office performs stem cell injections of any kind, and nothing described below is available here. What the practice does run is the non-surgical joint and tendon recovery program at both Florida offices. It is drug-free and injection-free, built on acoustic wave therapy, knee decompression and hands-on soft tissue work.
The trial is still worth reading about. Patients bring printouts into exam rooms, and they deserve a straight account of what it did and did not show.
What Did the Mayo Clinic Trial Actually Test?
The study is registered as NCT03308565 and runs under the name CELLTOP. Researchers took fat tissue from each participant and grew mesenchymal stem cells from it in a laboratory over several weeks. Those cells were then delivered into the fluid around the spinal cord through a lumbar puncture.
Using a person's own cells sidesteps the immune rejection problem that comes with donor tissue. The delivery route matters too. An intrathecal injection puts the cells into cerebrospinal fluid rather than into the cord itself, which avoids operating on damaged tissue a second time.
Who Took Part and What Changed for Them?
Ten people enrolled. All of them had been graded A or B on the American Spinal Injury Association Impairment Scale at the time of injury. Those are the two most severe categories.
At final follow-up, seven of the ten had improved by at least one grade on that scale. A grade change is a meaningful thing. It can mean sensation returning below the level of injury, or muscle activity appearing where there was none. It is not the same as walking, and the published paper does not claim that it is.
The first person treated was described separately four years earlier. He was a 53-year-old man with a high cervical grade A injury from a surfing accident. His neurological recovery had already flattened out within six months. He later improved to grade C.
Was It Safe?
Safety was the primary question the trial was designed to answer, and the answer was reassuring rather than perfect. The most common adverse events were headache and musculoskeletal pain, reported in eight of the ten participants. No serious adverse events occurred.
That distinction is worth holding onto. Some coverage of this trial states that no adverse effects were reported at all, which is not what the paper says. Eight people had side effects. None of them were serious. Those are two different sentences, and the second one is the accurate one.
Why Is a Phase 1 Result Not Yet a Treatment?
Phase 1 trials are small and they carry no control group. That means nobody can separate what the cells did from what intensive rehabilitation, time and the ordinary variability of spinal cord recovery did. Seven improvements in ten people is a signal that justifies a larger study. It is not evidence of effect.
Later-phase research adds comparison groups, larger numbers and blinded assessors. Until that work is done and published, no clinic anywhere can honestly sell this as a treatment for spinal cord injury. The path from a phase 1 pilot to routine care usually runs for years.
If you are reading this because someone you love has a spinal cord injury, here is the useful frame. Be patient with the science, and skeptical toward anyone charging for it today.
What Does the Practice Offer for Spine and Nerve Symptoms Instead?
Spinal cord injury is a different category of problem from the disc, joint and nerve-irritation complaints treated here. It belongs with a spinal cord specialist and a rehabilitation team.
For mechanical spine problems, the tools at both Central Florida offices are conservative ones. Table-based decompression for disc and nerve symptoms applies gentle traction to open the space between vertebrae, which can ease pressure on an irritated nerve root. It is used for sciatica, disc-related leg pain and neck pain that travels into an arm. If you want the mechanics of it, how decompression eases pressure on an irritated spinal nerve covers the same ground in more detail.
How Should You Read a Stem Cell Claim You See Advertised?
Four questions will separate a research program from a sales pitch, and you can ask all of them on the phone.
- What exactly is being injected, and where does the material come from?
- Is this specific use registered as a clinical trial, and what is the number?
- What published evidence exists for my condition, as opposed to testimonials?
- What is the total cost in writing, and what happens if nothing changes?
A clinic doing legitimate research will answer all four without hesitation. A clinic that redirects to success stories, or that quotes a price before examining you, has told you what you need to know.
Where This Leaves an Ordinary Patient in Central Florida
Regenerative research is moving, and the Mayo Clinic result is a real piece of it. It is also ten people, one site, and no control group. Both things are true at once, and holding them together is the honest position.
Meanwhile the unglamorous conservative options still do most of the work for most people. Soft tissue work that keeps a joint moving after an injury will not make headlines, and it is not a treatment for spinal cord injury. For the stiff shoulder, the worn knee or the low back that locks after a drive, it is what the evidence supports. It is also what this practice actually delivers. New patients start with a consultation, exam, X-rays if needed and a report of findings for $47.
Frequently Asked Questions
Ready to take the next step?
Talk with the ChiroMed team about a sports medicine clinic plan built around what your examination actually finds.